Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating abatacept with standard therapy versus standard therapy alone in adults with active inflammatory myopathy (polymyositis and dermatomyos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Necrotizing Myopathy
• Dermatomyositis
• Juvenile Myositis Above the Age of 18
• Overlap Myositis
• Polymyositis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Polymyositis, Dermatomyositis | Phase 3 | Status: COMPLETED | Results posted: 2021-09-17